Your browser doesn't support javascript.
loading
Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19.
Bellmann-Weiler, Rosa; Lanser, Lukas; Burkert, Francesco; Seiwald, Stefanie; Fritsche, Gernot; Wildner, Sophie; Schroll, Andrea; Koppelstätter, Sabine; Kurz, Katharina; Griesmacher, Andrea; Weiss, Günter.
Afiliação
  • Bellmann-Weiler R; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Lanser L; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Burkert F; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Seiwald S; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Fritsche G; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Wildner S; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Schroll A; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Koppelstätter S; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Kurz K; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
  • Griesmacher A; Central Institute for Medical and Chemical Laboratory Diagnosis, Innsbruck University Hospital, Innsbruck, Austria.
  • Weiss G; Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria.
Open Forum Infect Dis ; 8(1): ofaa521, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33442554
ABSTRACT
This study evaluates the predictive value of circulating inflammatory markers, especially neopterin, in patients with coronavirus disease 2019 (COVID-19). Within this retrospective analysis of 115 hospitalized COVID-19 patients, elevated neopterin levels upon admission were significantly associated with disease severity, risk for intensive care unit admission, need for mechanical ventilation, and death. Therefore, neopterin is a reliable predictive marker in patients with COVID-19 and may help to improve the clinical management of patients.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article